{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:04:33Z","timestamp":1790546673178,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier","isbn-type":[{"value":"9780128203354","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.mcb.2019.05.006","type":"book-chapter","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T21:34:45Z","timestamp":1560807285000},"page":"109-120","source":"Crossref","is-referenced-by-count":14,"title":["Manipulation of renal gene expression using oligonucleotides"],"prefix":"10.1016","author":[{"given":"Ronak","family":"Lakhia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abheepsa","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.mcb.2019.05.006_bb0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1042\/bst0240630","article-title":"Second-generation antisense oligonucleotides: Structure-activity relationships and the design of improved signal-transduction inhibitors","volume":"24","author":"Altmann","year":"1996","journal-title":"Biochemical Society Transactions"},{"issue":"6","key":"10.1016\/bs.mcb.2019.05.006_bb0015","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1742-4658.2009.06908.x","article-title":"Ribonuclease H: The enzymes in eukaryotes","volume":"276","author":"Cerritelli","year":"2009","journal-title":"The FEBS Journal"},{"issue":"3","key":"10.1016\/bs.mcb.2019.05.006_bb0020","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.3779","article-title":"Cellular uptake and trafficking of antisense oligonucleotides","volume":"35","author":"Crooke","year":"2017","journal-title":"Nature Biotechnology"},{"issue":"4","key":"10.1016\/bs.mcb.2019.05.006_bb0025","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/bs.mcb.2019.05.006_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/oli.1.2000.10.117","article-title":"Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them?","volume":"10","author":"Eckstein","year":"2000","journal-title":"Antisense & Nucleic Acid Drug Development"},{"issue":"6836","key":"10.1016\/bs.mcb.2019.05.006_bb0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.mcb.2019.05.006_bb0040","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/nar\/gkg185","article-title":"In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides","volume":"31","author":"Fluiter","year":"2003","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/bs.mcb.2019.05.006_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI75852","article-title":"Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways","volume":"125","author":"Gomez","year":"2015","journal-title":"The Journal of Clinical Investigation"},{"issue":"13","key":"10.1016\/bs.mcb.2019.05.006_bb0050","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1073\/pnas.92.13.5798","article-title":"Oligonucleotide N3\u2032-->P5\u2032 phosphoramidates","volume":"92","author":"Gryaznov","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.mcb.2019.05.006_bb0055","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/nar\/24.8.1508","article-title":"Oligonucleotide N3\u2032-->P5\u2032 phosphoramidates as antisense agents","volume":"24","author":"Gryaznov","year":"1996","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.mcb.2019.05.006_bb0060","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1038\/ncomms14395","article-title":"microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/bs.mcb.2019.05.006_bb0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.2007030299","article-title":"Polycystic kidney disease","volume":"18","author":"Igarashi","year":"2007","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"16","key":"10.1016\/bs.mcb.2019.05.006_bb0070","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0960-894X(98)00366-7","article-title":"The first analogues of LNA (locked nucleic acids): Phosphorothioate-LNA and 2\u2032-thio-LNA","volume":"8","author":"Kumar","year":"1998","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"8","key":"10.1016\/bs.mcb.2019.05.006_bb0075","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1681\/ASN.2015060634","article-title":"MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease","volume":"27","author":"Lakhia","year":"2016","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"5689","key":"10.1016\/bs.mcb.2019.05.006_bb0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1126\/science.1102513","article-title":"Argonaute2 is the catalytic engine of mammalian RNAi","volume":"305","author":"Liu","year":"2004","journal-title":"Science"},{"issue":"2","key":"10.1016\/bs.mcb.2019.05.006_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Molecular Cell"},{"key":"10.1016\/bs.mcb.2019.05.006_bb0090","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1995.406","article-title":"Renal uptake of an 18-mer phosphorothioate oligonucleotide","volume":"48","author":"Oberbauer","year":"1995","journal-title":"Kidney International"},{"issue":"26","key":"10.1016\/bs.mcb.2019.05.006_bb0095","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1073\/pnas.1301693110","article-title":"miR-17~92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease","volume":"110","author":"Patel","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/bs.mcb.2019.05.006_bb0100","first-page":"14","article-title":"Fomivirsen approved for CMV retinitis","volume":"4","author":"Roehr","year":"1998","journal-title":"Journal of the International Association of Physicians in AIDS Care"},{"issue":"4","key":"10.1016\/bs.mcb.2019.05.006_bb0105","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.cell.2009.02.007","article-title":"The centrality of RNA","volume":"136","author":"Sharp","year":"2009","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.mcb.2019.05.006_bb0110","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1093\/nar\/16.8.3209","article-title":"Physicochemical properties of phosphorothioate oligodeoxynucleotides","volume":"16","author":"Stein","year":"1988","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/bs.mcb.2019.05.006_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.75.1.285","article-title":"Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide","volume":"75","author":"Stephenson","year":"1978","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.mcb.2019.05.006_bb0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-4781(99)00150-5","article-title":"Morpholino antisense oligomers: The case for an RNase H-independent structural type","volume":"1489","author":"Summerton","year":"1999","journal-title":"Biochimica et Biophysica Acta"},{"issue":"6","key":"10.1016\/bs.mcb.2019.05.006_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/9304","article-title":"Crystal structure and improved antisense properties of 2'-O-(2-methoxyethyl)-RNA","volume":"6","author":"Teplova","year":"1999","journal-title":"Nature Structural Biology"},{"key":"10.1016\/bs.mcb.2019.05.006_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0076-6879(00)17007-7","article-title":"Phosphorothioate modification of RNA for stereochemical and interference analyses","volume":"317","author":"Vortler","year":"2000","journal-title":"Methods in Enzymology"},{"issue":"17","key":"10.1016\/bs.mcb.2019.05.006_bb0135","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1073\/pnas.1818522116","article-title":"Regenerative therapy based on miRNA-302 mimics for enhancing host recovery from pneumonia caused by Streptococcus pneumoniae","volume":"116","author":"Wang","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.mcb.2019.05.006_bb0140","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41598-019-38566-y","article-title":"Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth","volume":"9","author":"Yheskel","year":"2019","journal-title":"Scientific Reports"}],"container-title":["Methods in Cell Biology","Methods in Kidney Cell Biology - Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X19300755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X19300755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T14:14:44Z","timestamp":1567606484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X19300755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128203354"],"references-count":27,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2019.05.006","relation":{},"ISSN":["0091-679X"],"issn-type":[{"value":"0091-679X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}